ArticleOncotarget2016

Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials.

J Andrew Livingston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.